Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
(A) Dose-dependent cytotoxicity and IC50 values of QMNPs on MCF-7 ...
Maytansinoids as Payloads of ADCs: DM1, DM4 | Biopharma PEG
The IC50 values of different drugs and their combinations after 48 h ...
Antibody Drug Conjugate Dm4 Mechanism Diagram
a. Antiproliferative activities and IC50 of MMAE and 1 with or without ...
The IC50 of Different Drugs to the Cervical Cancer Cells at 24h and 48h ...
The IC50 values of ABT199 (venetoclax) and CS055 (chidamide) on AML ...
Covariate analysis of tusamitamab ravtansine, a DM4 anti‐CEACAM5 ...
IC50 values of various drugs tested for anti-cancer activity in ...
IC50 values of DOX⋅HCl against (A) MCF-7/ADR cells and (B) K562/ADR ...
Dose-response curve of IC50 for Tamoxifen on MCF-7. | Download ...
The IC50 of osimertinib in EGFR‐mutant NSCLC cells, diluted in ...
Relationship between mefloquine IC50 and Pfmdr1 status. A Correlation ...
The IC50 values of the excipients tested in the Calu-3 cell line and ...
IC50 measurement of the inhibition of S-protein RBD (BA.4/BA.5) binding ...
The inhibitory potency in IC50 or EC50, cytotoxicity, and selectivity ...
The IC50 of the compounds 2A-2E for A549 cells. IC50: half maximal ...
IC50 values of different cytotoxic drugs in our four cell models. The ...
Assessment of Cell Viability in Drug Therapy: IC50 and Other New Time ...
MCC-DM1 and SPDB- DM4 motifs used in the clinical candidates listed in ...
IC50 analyses of four inhibitors for selected DUBs. A subset of four ...
Determination of the half-maximum inhibitory concentration (IC 50 ) of ...
History of ADC Payloads and Its Pharmacokinetic Profiles - BOC Sciences
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an ...
Advancing Antibody-Drug Conjugates (ADCs) with Novel Payloads and Their ...
WO2021113740A1 - Compositions and methods for reducing off-target ...
Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell ...
Antibody–Drug Conjugate Payloads: MMAE & MMAF | Biopharma PEG
Antibody Co-Administration Can Improve Systemic and Local Distribution ...
Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness ...
ADC各大毒素如何选择？IC50、作用机制、临床管线（附全景布局图）_细胞_他汀_蛋白
A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent ...
Antibody Drug Conjugates (ADC) | BroadPharm
Main elements of antibody-drug conjugate (ADC)：Toxins/Payloads ...
Methods for the Generation of Single‐Payload Antibody‐Drug Conjugates - PMC
Antibody-drug Conjugates - BOC Sciences
Antibody Drug Conjugate Services | Biocytogen
Antibody–Drug Conjugates: Ushering in a New Era of Cancer Therapy
Antibody–drug conjugates: Recent advances in payloads - PMC
Antibody–Drug Conjugates for Multiple Myeloma: Just the Beginning, or ...
Importance and Considerations of Antibody Engineering in Antibody-Drug ...
Antibody–Drug Conjugate Efficacy in Neuroblastoma: Role of Payload ...
Antibody Drug Conjugates: Design and Selection of Linker, Payload and ...
Innovations in Antibody-Drug Conjugate (ADC) in the Treatment of Lymphoma
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
(PDF) A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits ...
Immunotherapy: antibody drug conjugates from a small molecule perspective
A Novel Antibody Drug Conjugate Against Pancreatic Cancer ...
Antibody drug conjugates current status and future perspectives | PPTX
Drug concentrations required to induce the 50% apoptotic cells (IC50 ...
A Dual-Payload Antibody–Drug Conjugate Targeting CD276/B7-H3 Elicits ...
A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating ...
Intracellular Released Payload Influences Potency and Bystander-Killing ...
Frontiers | Chimeric antigen receptor-T cells are effective against ...
Antibody–Drug Conjugates: The Last Decade
Unveiling the future of breast cancer therapy: Cutting-edge antibody ...
Methods for the Generation of Single‐Payload Antibody‐Drug Conjugates ...
Immune Modulating Antibody–Drug Conjugate (IM-ADC) for Cancer ...
Half‐maximal inhibitory concentrations (IC50) for etoposide and SN‐38 ...
(PDF) Antibody-drug conjugates with dual payloads for combating breast ...
Exploring the sensitivity of antibody-drug conjugate efficacy to the ...
Oncology Reports
Cytotoxicity and The half maximal inhibitory concentration (IC50) of C ...
NJ Bio, Inc. — Recent Advances in ADCs
Antibody-drug conjugates with dual payloads for combating breast tumor ...
Antibody–Drug Conjugates—A Tutorial Review
Physicochemical parameters of antibody-drug conjugate payloads ...
Frontiers | Conditional activation of an anti-IgM antibody-drug ...
Antibody Conjugates-Recent Advances and Future Innovations
(PDF) Payload diversification: a key step in the development of ...
(R)-DM4-SPDP | Antibody-drug Conjugates | MedChemExpress
Pharmacokinetics of antibody drug conjugates loaded with 4 ...
Antibody–Drug Conjugates | SpringerLink
Understanding the Preclinical Efficacy of Antibody–Drug Conjugates
Antibody Drug Conjugate Structure
Differences in the antiproliferative capacity of AZD8055 and rapamycin ...
An Insight into FDA Approved Antibody-Drug Conjugates for Cancer ...
Improved Tumor Penetration and Single-Cell Targeting of Antibody–Drug ...
Delivery of Drugs into Cancer Cells Using Antibody–Drug Conjugates ...
Dual-specificity phosphatase 8 (DUSP8) induces drug resistance in ...
A Selective Small Molecule DNA2 Inhibitor for Sensitization of Human ...
Cytotoxicity (IC50) and anticancer activity of tested polysaccharides ...
Cytotoxicity (CC50) and antiviral activity (IC50) for C. papaya total ...
Half maximal inhibitory concentration (IC50) of TA0 and its ...
Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical ...
Current Trends in the Clinical Development of Antibody-Drug Conjugates ...
Antibody–Drug Conjugates: A Comprehensive Review | Molecular Cancer ...
Graph of inhibitory concentration 50 (IC50): Antiviral activity against ...
Multi-Payload Antibody–Drug Conjugates: Advancing Targeted Cancer ...
